Effect of alendronate on bone remodeling around implant in the rat |
Park, Ran
(Department of Prosthodontics, Oral Science Research Center, Yonsei University College of Dentistry)
Kim, Jee-Hwan (Department of Prosthodontics, Oral Science Research Center, Yonsei University College of Dentistry) Choi, Hyunmin (Department of Prosthodontics, Oral Science Research Center, Yonsei University College of Dentistry) Park, Young-Bum (Department of Prosthodontics, Oral Science Research Center, Yonsei University College of Dentistry) Jung, Han-Sung (Division in Anatomy and Developmental Biology, Department of Oral Biology, Oral Science Research Center, Yonsei University College of Dentistry) Moon, Hong-Seok (Department of Prosthodontics, Oral Science Research Center, Yonsei University College of Dentistry) |
1 | Mashiba T, Turner CH, Hirano T, Forwood MR, Jacob DS, Johnston CC, Burr DB. Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures. Bone 2001;29:271-8. DOI ScienceOn |
2 | Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 2001;28:524-31. DOI ScienceOn |
3 | Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003;349:457-63. DOI ScienceOn |
4 | Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005;90:1294-301. DOI ScienceOn |
5 | Visekruna M, Wilson D, McKiernan FE. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 2008;93:2948-52. DOI ScienceOn |
6 | Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 2000;88:2961-78. DOI ScienceOn |
7 | Russell RG. Bisphosphonates: mode of action and pharmacology. Pediatrics 2007;119:S150-62. DOI ScienceOn |
8 | Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev 1998;19:80-100. DOI |
9 | Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 1993;92:2577-86. DOI ScienceOn |
10 | Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 1997;100:1475-80. DOI ScienceOn |
11 | Yang Li C, Majeska RJ, Laudier DM, Mann R, Schaffler MB. High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse. Bone 2005;37:287-95. DOI ScienceOn |
12 | Weinstein RS, Roberson PK, Manolagas SC. Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 2009;360:53-62. DOI ScienceOn |
13 | Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001;16:1575-82. DOI ScienceOn |
14 | Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J Bone Miner Metab 2008;26:260-4. DOI |
15 | Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM, Castronovo V, Green JR. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302:1055-61. DOI ScienceOn |
16 | Rubin CT, Bain SD, McLeod KJ. Suppression of the osteogenic response in the aging skeleton. Calcif Tissue Int 1992; 50:306-13. DOI ScienceOn |
17 | Klein-Nulend J, Sterck JG, Semeins CM, Lips P, Joldersma M, Baart JA, Burger EH. Donor age and mechanosensitivity of human bone cells. Osteoporos Int 2002;13:137-46. DOI |
18 | Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008;83:1032-45. DOI ScienceOn |
19 | Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7. DOI ScienceOn |
20 | Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34. DOI ScienceOn |
21 | Allen MR, Burr DB. The pathogenesis of bisphosphonaterelated osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 2009;67:61-70. |
22 | Hikita H, Miyazawa K, Tabuchi M, Kimura M, Goto S. Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats. J Bone Miner Metab 2009;27:663-72. DOI |
23 | Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto- Nakano M, Hata K, Yatani H, Yoneda T. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab 2010; 28:165-75. DOI |
24 | Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg 2010;68:790-6. DOI ScienceOn |
25 | Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg 2008;66: 223-30. DOI ScienceOn |
26 | Smith SY, Recker RR, Hannan M, Müller R, Bauss F. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys. Bone 2003;32:45-55. DOI ScienceOn |
27 | Allen MR, Kubek DJ, Burr DB. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs. J Bone Miner Res 2010;25:98-105. DOI |
28 | Listgarten MA. Soft and hard tissue response to endosseous dental implants. Anat Rec 1996;245:410-25. DOI ScienceOn |
29 | Ruggiero SL, Drew SJ. Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 2007;86:1013-21. DOI ScienceOn |
30 | Futami T, Fujii N, Ohnishi H, Taguchi N, Kusakari H, Ohshima H, Maeda T. Tissue response to titanium implants in the rat maxilla: ultrastructural and histochemical observations of the bone-titanium interface. J Periodontol 2000;71: 287-98. DOI ScienceOn |
31 | Masuda T, Yliheikkilä PK, Felton DA, Cooper LF. Generalizations regarding the process and phenomenon of osseointegration. Part I. In vivo studies. Int J Oral Maxillofac Implants 1998;13:17-29. |
32 | Pereira MC, Zecchin KG, Campagnoli EB, Jorge J. Ovariectomy delays alveolar wound healing after molar extractions in rats. J Oral Maxillofac Surg 2007;65:2248-53. DOI ScienceOn |
33 | Fujii N, Kusakari H, Maeda T. A histological study on tissue responses to titanium implantation in rat maxilla: the process of epithelial regeneration and bone reaction. J Periodontol 1998;69:485-95. DOI ScienceOn |
34 | Karimbux NY, Sirakian A, Weber HP, Nishimura I. A new animal model for molecular biological analysis of the implant- tissue interface: spatial expression of type XII collagen mRNA around a titanium oral implant. J Oral Implantol 1995;21:107-13; discussion 114-5. |
35 | Shimizu M, Sasaki T, Ishihara A, Furuya R, Kawawa T. Bone wound healing after maxillary molar extraction in ovariectomized aged rats. J Electron Microsc (Tokyo) 1998;47:517-26. DOI ScienceOn |
36 | Bi Y, Gao Y, Ehirchiou D, Cao C, Kikuiri T, Le A, Shi S, Zhang L. Bisphosphonates cause osteonecrosis of the jawlike disease in mice. Am J Pathol 2010;177:280-90. DOI ScienceOn |
37 | Kikuiri T, Kim I, Yamaza T, Akiyama K, Zhang Q, Li Y, Chen C, Chen W, Wang S, Le AD, Shi S. Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonaterelated osteonecrosis of the jaw-like disease in mice. J Bone Miner Res 2010;25:1668-79. DOI |